Indiana Clinical Trials

Recruiting studies in Indiana

• A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
  NCT07431177PHASE2Novartis PharmaceuticalsNon-segmental VitiligoIndianapolis, IN
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
  NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerIndianapolis, IN
• A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
  NCT05947851PHASE3Merck Sharp & Dohme LLCLeukemia, Lymphocytic, Chronic, B-CellFort Wayne, IN
• Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
  NCT06581432PHASE2Boehringer IngelheimSolid TumoursIndianapolis, IN
• A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
  NCT07700056PHASE3Novartis PharmaceuticalsChronic Pruritus of Unknown OriginIndianapolis, IN
• A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
  NCT06541704PHASE3Regeneron PharmaceuticalsAge-related Macular Degeneration (AMD)Carmel, IN
• MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
  NCT05564390PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaIndianapolis, IN
• Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
  NCT07195734PHASE2National Cancer Institute (NCI)Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
• Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
  NCT07042295PHASE2National Cancer Institute (NCI)Locally Recurrent Skin Squamous Cell CarcinomaCrown Point, IN
• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
  NCT06430801PHASE3Merck Sharp & Dohme LLCCrohn's DiseaseIndianapolis, IN
• Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
  NCT07828860PHASE1Corvus Pharmaceuticals, Inc.Hidradenitis Suppurativa (HS)West Lafayette, IN
• SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
  NCT07187531PHASE2SAb Biotherapeutics, Inc.Type 1 DiabetesIndianapolis, IN

See all 1,208 recruiting trials →

Clinical trials by Indiana metro

• Indianapolis

Popular conditions in Indiana

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Indiana?

Corterve aggregates actively recruiting clinical trials with sites in Indiana from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.

Are clinical trials in Indiana free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

What kinds of clinical trials are available in Indiana?

Indiana research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.